Response to comments on: Clinical profile of uveitis patients developing central serous chorioretinopathy - An experience at a tertiary eye care center in India.

For example, it will be difficult to calculate the cumulative dose of steroids in our patients - as 6 of our 26 patients were using topical steroids, and 2 developed CSC following periocular steroid injections.[[2]] Moreover, the development of CSC is not always dose-dependent. Further, corticosteroid, in any form, is usually avoided in patients with a history of CSC and none of our patients had a history of CSC. [Extracted from the article]